Chicago Bridge & Iron Company N.V. (CBI) 29.57 $CBI CB&I

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Chicago Bridge & Iron Company N.V. (CBI) 29.57 $CBI

CB&I to Participate in D.A. Davidson 15th Annual Engineering & Construction Conference
PR Newswire - Wed Aug 31, 7:00AM CDT
CB&I (NYSE:CBI) today announced it will participate in the 15th annual D.A. Davidson Engineering & Construction Conference in San Francisco on Wednesday, Sept. 7, 2016.
CBI: 29.57 (-0.16)

CB&I Announces Facilities Restoration and Modernization Contract at Arnold Air Force Base
PR Newswire - Tue Aug 30, 7:00AM CDT
CB&I (NYSE:CBI) today announced it has been awarded a multi-year contract with a value to CB&I of approximately $75 million by the Air Force Test Center at Arnold Air Force Base in Tullahoma, Tennessee. CB&I's scope of work includes plant and infrastructure sustainment, restoration and modernization to support the center's research, development, test and evaluation mission.
CBI: 29.57 (-0.16)

SmarTrend Watching for Potential Rebound in Shares of Chicago Bridge & Iron After 1.05% Loss
Comtex SmarTrend(R) - Fri Aug 26, 2:55PM CDT
Chicago Bridge & Iron (NYSE:CBI) traded in a range yesterday that spanned from a low of $31.07 to a high of $31.97. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $31.27 on volume of 518,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CBI: 29.57 (-0.16)

Research Reports Coverage on Industrial Goods Stocks -- Quanta Services, Chicago Bridge & Iron, Fluor, and Dycom Industries
PR Newswire - Thu Aug 25, 7:05AM CDT
Today, Stock-Callers.com assesses the Industrial Goods sector which includes companies that provide capital goods and commercial services, manufactures aerospace and defense equipment, and offer services such as transportation, infrastructure, data processing, human resources, consulting, environmental, security, and printing. Stocks under review are: Quanta Services Inc. (NYSE: PWR), Chicago Bridge & Iron Co. N.V. (NYSE: CBI), Fluor Corp. (NYSE: FLR), and Dycom Industries Inc. (NYSE: DY). These stocks research reports can be downloaded now by simply registering for free at: http://stock-callers.com/registration
CBI: 29.57 (-0.16), PWR: 26.22 (+0.06), FLR: 51.23 (-0.91), DY: 85.56 (-0.64)

Significant Chicago Bridge & Iron Company N.V. Shareholder, Cohen Capital Management, Calls for Immediate Change in Failed Senior Leadership
BusinessWire - Wed Aug 24, 7:00AM CDT
--Letter Notes that Chicago Bridge & Iron Company N.V. Has Destroyed $6 Billion of Shareholder Value in Less Than Two Years and Squandered Shareholder Capital on Failed Shaw Group Transaction
CBI: 29.57 (-0.16)

Chicago Bridge & Iron (CBI) Clinches a $350M Contract
Zacks Equity Research - Zacks Investment Research - Thu Aug 11, 8:01AM CDT
Global engineering, procurement and construction conglomerate Chicago Bridge & Iron Company N.V. (CBI) recently secured a $350 million contract from a renowned electric power holding company.
CBI: 29.57 (-0.16), EME: 57.67 (-0.28), WLDN: 18.00 (+0.04), MTZ: 29.73 (+0.11)

CB&I Announces Award for 560-Megawatt Dual-Fuel Combined-Cycle Gas Turbine Power Station
PR Newswire - Wed Aug 10, 7:00AM CDT
CB&I (NYSE:CBI) today announced it has been awarded a contract valued at more than $350 million by a leading electric power holding company for the engineering, procurement, fabrication and construction of a 560-megawatt combined-cycle gas turbine power station located in the Southeastern United States. The project will utilize gas turbines capable of operating on a dual-fuel configuration that provides efficiency, reliability, and operational and fuel flexibility.
CBI: 29.57 (-0.16)

After Yesterday's Decline of 2.76%, Chicago Bridge & Iron Offers Investors Better Value
Comtex SmarTrend(R) - Thu Jul 28, 2:14PM CDT
Chicago Bridge & Iron (NYSE:CBI) traded in a range yesterday that spanned from a low of $34.57 to a high of $36.02. Yesterday, the shares fell 2.8%, which took the trading range below the 3-day low of $34.71 on volume of 1.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CBI: 29.57 (-0.16)

Chicago Bridge & Iron (CBI) Lags Q2 Earnings, Guides Down
Zacks Equity Research - Zacks Investment Research - Thu Jul 28, 8:40AM CDT
Chicago Bridge & Iron Company N.V. (CBI) reported second-quarter 2016 adjusted earnings of $1.17 per share, which missed the Zacks Consensus Estimate of $1.22 by a nickel.
CBI: 29.57 (-0.16), DY: 85.56 (-0.64), WLDN: 18.00 (+0.04), MTZ: 29.73 (+0.11)

CB&I Reports Second-Quarter 2016 Financial Results
PR Newswire - Wed Jul 27, 3:15PM CDT
CB&I (NYSE: CBI) today reported net income of $123.8 million, or $1.17 per diluted share, for the second quarter of 2016, as compared to $169.5 million, or $1.55 per diluted share for the second quarter of 2015. On an adjusted basis, net income for the second quarter of 2015 was $125.7 million, or $1.15 per diluted share.
CBI: 29.57 (-0.16)

Albemarle (ALB) Set to be Added to the S&P 500 Index
Zacks Equity Research - Zacks Investment Research - Fri Jun 24, 5:53AM CDT
Albemarle Corporation (ALB) is slated to join the S&P 500 index after the market closes on Jun 30, 2016.
CBI: 29.57 (-0.16), TE: 27.64 (-0.01), ALB: 83.04 (+1.08)

CB&I Announces Technology and Development Contract for Residue Upgrading Complex in Sweden
PR Newswire - Thu Jun 16, 3:16PM CDT
CB&I (NYSE:CBI) today announced Chevron Lummus Global, a joint venture between CB&I and Chevron, has been awarded a contract by Beowulf Energy Sweden LLC, who recently signed a cooperation agreement with Preem, for the technology license and development of a residue upgrading complex in Lysekil, Sweden. The scope of the contract includes the license of Chevron Lummus Global's LC-Slurry® technology with integrated ISOCRACKING® and ancillary units. Under the agreement, CB&I also will develop a detailed cost estimate and execution plan for the engineering, procurement and construction phase of the project.
CBI: 29.57 (-0.16)

Industrial Goods Sector Stocks Technical Coverage -- Quanta Services, Chicago Bridge & Iron, Summit Materials, and Vulcan Materials
PR Newswire - Thu Jun 16, 7:20AM CDT
On Wednesday, June 15, 2016, the NASDAQ Composite ended the trading session at 4,834.93, down 0.18%; the Dow Jones Industrial Average edged 0.20% lower to finish at 17,640.17; and the S&P 500 closed at 2,071.50, down 0.18%. However, six out of nine sectors ended the session in positive. Stock-Callers.com has initiated coverage on the following equities: Quanta Services Inc. (NYSE: PWR), Chicago Bridge & Iron Company N.V. (NYSE: CBI), Summit Materials Inc. (NYSE: SUM), and Vulcan Materials Company (NYSE: VMC). Learn more about these stocks by accessing their free trade alerts at:
CBI: 29.57 (-0.16), PWR: 26.22 (+0.06), VMC: 112.96 (-1.52), SUM: 18.89 (-0.70)

Albemarle (ALB) Acclaimed for Green AlkyClean Technology
Zacks Equity Research - Zacks Investment Research - Wed Jun 15, 6:29AM CDT
The U.S. Environmental Protection Agency presented Albemarle Corporation (ALB) with the 2016 Presidential Green Chemistry Challenge Award on Jun 13, 2016.
CBI: 29.57 (-0.16), ALB: 83.04 (+1.08), AXLL: 33.00 (+0.02), DOW: 53.90 (-0.28)

EPA Honors CB&I with Presidential Green Chemistry Challenge Award
PR Newswire - Tue Jun 14, 7:00AM CDT
CB&I (NYSE:CBI) today announced it has been awarded the 2016 Presidential Green Chemistry Challenge award from the U.S. Environmental Protection Agency for its AlkyClean® process technology, a solid acid catalyst alkylation technology jointly developed by CB&I, Albermarle and Neste Oil.
CBI: 29.57 (-0.16)

CB&I's 10 Top-Valued Projects Fueled by Major LNG Projects on Four Continents, an Industrial Info News Alert
Marketwired - Fri Jun 10, 6:30AM CDT
SUGAR LAND, TX--(Marketwired - Jun 10, 2016) - Researched by Industrial Info Resources (Sugar Land, Texas) -- CB&I Incorporated (NYSE:CBI) (The Hague, Netherlands), also known as Chicago Bridge & Iron Company, is maintaining a healthy slate of projects, despite a slowing business environment due to the consistent weakness in commodity prices. According to Industrial Info's project database, CB&I is involved in more than 140 projects, with a total investment value (TIV) of $175.6 billion. More than half of the TIV is attributed to the 10 highest-valued projects, all of which involve construction and additions at liquefied natural gas (LNG) facilities.
CBI: 29.57 (-0.16), SRE: 106.09 (+1.79), CVX: 102.43 (+1.50), APC: 57.19 (+0.70)

CB&I to Participate in Investor Conferences in Boston and Chicago
PR Newswire - Tue Jun 07, 7:00AM CDT
CB&I (NYSE:CBI) today announced it will participate in two upcoming investor conferences.
CBI: 29.57 (-0.16)

After Yesterday's Rally of 2.05% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue May 31, 5:07PM CDT
Chicago Bridge & Iron (NYSE:CBI) traded in a range yesterday that spanned from a low of $37.80 to a high of $38.89. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $37.94 on volume of 726,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CBI: 29.57 (-0.16)

Look for Shares of Chicago Bridge & Iron to Potentially Pullback after Yesterday's 1.59% Rise
Comtex SmarTrend(R) - Fri May 27, 1:39PM CDT
Chicago Bridge & Iron (NYSE:CBI) traded in a range yesterday that spanned from a low of $36.89 to a high of $37.94. Yesterday, the shares gained 1.6%, which took the trading range above the 3-day high of $37.78 on volume of 672,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
CBI: 29.57 (-0.16)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

GlycoNex Eyes Japanese Market with Denosumab Biosimilar

Updated Category News Views 120

A Strategic Step into the Japanese Market Alright folks, there's a new kid aiming to shake things up in the biotech neighborhood, and it's GlycoNex with its denosumab biosimilar, SPD8. These guys just tossed their hat in the ring with a regulatory submission to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If the cosmic forces align, they might snag an...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 99

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 710

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
Onodrim Raises $300M to Propel EU Defence Future

Updated Category News Views 20

Onodrim Industries' Bold Bid to Reshape European Security Right out of the gate, Onodrim Industries is thundering onto the scene with a hefty $300 million Series A round to flex its muscles across Europe's defence and industrial sectors. This ain't your run-of-the-mill startup story. This is about flexing hard-earned capital to snap up established players and inject a...

Continue Reading
Wuliangye Aims for Global Branding Boost at Panda Event

Updated Category News Views 179

Wuliangye Takes Center Stage at Global Event Everyone's chasing that global branding magic, but here's Wuliangye strutting its stuff at the Global Panda Partners Conference. Held in Sichuan Province from November 2 to 4, this is not just another show; it's a bold move from the Chinese baijiu maker to push the 'harmony and coexistence' mantra on the world stage. Not just...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 312

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
KT&G Launches Heated Tobacco in Kazakhstan's Market

Updated Category News Views 43

KT&G Lights Up Kazakhstan In a bold move, KT&G is laying down the gauntlet in Kazakhstan's tobacco market, introducing its cutting-edge heated tobacco gizmo and a handful of sleek FAIIM sticks. Launching this October, these aren't just any devices—they're the FLEX locals have been waiting for, rebranded from South Korea's lil AIBLE and AIIM but made to fit right in with...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 474

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
AI Shopping Surge: WeFetch.ai's Bold Rebrand Move

Updated Category News Views 134

Shifting Gears: GreenCore Solutions Becomes WeFetch.ai Here's a shift you don't see every day. GreenCore Solutions has morphed into WeFetch.ai, aiming to sail the ever-growing AI shopping seas. This isn't just a new nameplate; it's a declaration of intent to dive headfirst into the market dynamics driven by artificial intelligence. It's bold and, frankly, pretty timely....

Continue Reading
CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 172

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Traditions Bancorp Declares New Cash Dividend for Investors

Updated Category News Views 76

Traditions Bancorp Declares Quarterly Cash Dividend On a recent date, the Board of Directors of Traditions Bancorp (OTC: TRBK), the parent company of Traditions Bank, announced a quarterly cash dividend of eight cents per common share. This dividend reflects the company's strong commitment to returning value to its shareholders and will be disbursed shortly. The payment...

Continue Reading
LONGi BC Tech Paves the Way for Solar Leadership in Europe

Updated Category News Views 334

LONGi's Impact on Europe's Solar Industry LONGi, recognized as a leader in solar technology, has made remarkable strides in reshaping the renewable energy scene in Europe. With an impressive 10GW of back contact (BC) modules deployed, the continent is rapidly becoming a hotbed for high-efficiency solar solutions. This accomplishment underlines the company's crucial...

Continue Reading
PACS Group Investors: Important Actions to Take Now

Updated Category News Views 152

Important Deadline for PACS Group Investors Investors in PACS Group, Inc. are advised to take note of an important lead plaintiff application deadline related to recent securities class action lawsuits. If you have incurred losses exceeding $100,000 in the company's stock, you may be eligible to participate in these legal proceedings. Class Action Lawsuit Details The...

Continue Reading
Exploring Market Sentiment Around Morningstar Inc and Its Trends

Updated Category News Views 207

Understanding Morningstar Inc's Market Position Morningstar Inc (NYSE:MORN) has recently shown a notable decline in its short interest, with a decrease of 9.22% reported. Currently, there are approximately 655 thousand shares sold short, constituting about 2.56% of the total shares available for trading. This information is pivotal for investors since it reflects the...

Continue Reading
Julie Springer Expands Legal Services with Mediation Practice

Updated Category News Views 363

Julie Springer's New Ventures in Mediation In the dynamic legal scene of Austin, seasoned attorney Julie A. Springer is making waves by broadening her practice to include mediation and arbitration services. This thoughtful transition reflects her long-time dedication to effectively settling business disputes, educational conflicts, and employment issues. Professional...

Continue Reading